申请人:Miles Laboratories, Inc.
公开号:US04061760A1
公开(公告)日:1977-12-06
Compounds having the generic structure, ##STR1## and their nontoxic, pharmacologically acceptable salts are useful in the chemotherapy of arrhythmias in individuals for whom such therapy is indicated. In the preceding structural formula: R.sup.1 is a 2-pyridyl, 3-pyridyl, or 4-pyridyl radical; n is an integer of the set 1-3; and R.sup.2 is a hydrogen atom, a hydroxyl, or an equivalent alkoxyl group having from 1 to 3 carbon atoms.
具有通用结构## STR1##及其无毒、药理学上可接受的盐在心律失常化疗中对需要此类治疗的个体有用。在上述结构式中:R.sup.1是2-吡啶基、3-吡啶基或4-吡啶基基团;n为1-3的整数;R.sup.2是氢原子、羟基或具有1-3个碳原子的等效烷氧基团。